Spray drying has been used in the pharmaceutical industry for a variety of particle engineering and bioavailability enhancing applications. The process is continuous and readily scalable to accommodate the needs of programs from early feasibility assessments through large-scale commercial launch. Spray dried powders can be readily converted to solid dosage forms for oral dosing or dosed as dry powders with a specified device for inhaled applications. 

This webinar will focus on defining the spray drying process and the approach that Lonza uses to scale-up programs using this technology. Additionally, there will be emphasis on specific enhancements that have been made to the spray drying process to accommodate scale-up to commercial scale equipment of challenging applications or molecules, including those with extremely poor organic/water solubility and inhaled products.

 Key Learning Objectives:

  • Understand the spray drying process 
  • Discover how Lonza scales up programs while using this technology
  • Learn about enhancements in the spray drying process to accommodate scale-up of poorly soluble molecules and inhaled products
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center